News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Japan Spin-Out RaQualia Inks New R&D, Licensing Deals


12/22/2010 8:57:10 AM

Scripintelligence -- RaQualia Pharma, a drug development venture spun out from Pfizer's R&D operations in Japan, has taken further steps towards securing new revenue streams with the signing of research and licensing deals with Lilly and Durata Therapeutics.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES